Allscripts Healthcare Solutions
) has now come up with a real-time and point of care solution
Population Health Analytics that will help reduce high cost of
chronic disease management and check readmissions.
MDRX will demonstrate the Analytics solution at The Allscripts
Client Experience (ACE) at Chicago's McCormick Place from Aug 21
to 23. It provides analytics for costly and high priority chronic
maladies such as Diabetes, Heart Disease, Coronary Artery Disease
According to President and Chief Executive Officer of Allscripts,
Paul M. Black, its Population Health Analytics indicates a move
from individual patient care to population health care. The data
generated by the Analytics help physicians identify target
populations, measure performance and outcomes, and inform and
guide prompt clinical intervention for chronic ailments and
Allscripts Healthcare Solutions is a leading clinical software
and information solutions provider for physicians. Its products
are used widely across the U.S. and Canada. Currently, the
company serves approximately 180,000 physician practices, 1,500
hospitals, and 10,000 post acute care facilities.
Recently, Portland-Maine based Mercy Health System revealed that
it has chosen Allscripts Healthcare Solutions' Revenue Cycle
Management (RCM) Services in order to improve their reimbursement
processes at a lower cost and reduced implementation time. RCM
Services provide a complete revenue management solution from
front office to back office processing and patient collections.
A few days back, N.C.-based Appalachian Regional Healthcare
System also announced that it has implemented Allscripts
Healthcare Solutions' Electronic Health Record (EHR) system known
as Sunrise Clinical Manager (SCM). SCM will help Appalachian
maintain integrated patient records with the same graphical
interface across the health system.
Allscripts Healthcare Solutions posted a significant fall in
adjusted earnings to $2.2 million or a penny per share in the
second quarter of 2013 from $23.1 million or 13 cents in the
comparable quarter of 2012. With this, earnings also missed the
Zacks Consensus Estimate of 7 cents for the quarter.
Revenues in the quarter ebbed 6.8% to $344.8 million, again
missing the Zacks Consensus Estimate of $358 million. The
decrease can be attributable to lower revenues generated from all
the operating segments.
While we avoid MDRX being a Zacks Rank #4 (Sell) stock, other
scrips that are performing well in the medical products industry
), both with a Zacks Rank #1 (Strong Buy), and in the medical
information systems industry such as
Medidata Solutions, Inc.
) with a Zacks Rank #2 (Buy).
ALERE INC (ALR): Free Stock Analysis Report
HANGER ORTHOPED (HGR): Free Stock Analysis
ALLSCRIPTS HLTH (MDRX): Free Stock Analysis
MEDIDATA SOLUTN (MDSO): Free Stock Analysis
To read this article on Zacks.com click here.